Chloe didn’t deny what Eight said.
The problem seemed simple, but theoretically, it was impossible to solve.
Current treatments like radiation, chemotherapy, and targeted drugs could effectively treat leukemia, but the recurrence rate was still high.
After mulling it over for a long while with no success, Chloe exited the system.
She looked at her densely filled notebook and painstakingly circled an acronym—ATRA.
A drug primarily used for topical skin application.
Chloe narrowed her eyes slightly and marked it for emphasis.
She organized her notes one more time, then packaged them and sent them to Owen Warren.
The moment Owen Warren received the message, he immediately replied with three question marks.
"Boss, what’s ATRA?"
A moment later, Owen Warren sent another message:
"Why not use AML?"
They might start with the same letter, but the two were worlds apart.
The former was practically unrelated to leukemia.
If Chloe Sinclair weren’t such a legendary figure, Owen Warren would’ve thought he was dealing with a fraud.
Seeing his question, Chloe was about to type a reply.
But she paused halfway through.
AML was one of the most effective reagents on the market, and many leukemia studies mentioned it.
’But in three years, it will be discovered that AML requires preventative measures against hyperuricemia, acidosis, electrolyte imbalances, and coagulation abnormalities induced by leukemia cell lysis.’
’As a result, in the future, AML would become a drug of last resort for leukemia treatment.’
’However, it’s still in the clinical trial phase right now, so these problems haven’t emerged yet.’
There was still a lot of hype around AML in the current market, so it was perfectly normal for Owen Warren to want to use it.
Chloe paused and deleted what she had been typing.
’Without concrete research and published papers, she couldn’t just spout off about the results, even though she knew them.’


VERIFYCAPTCHA_LABEL
Comments
The readers' comments on the novel: From Trash to Treasure: The Sinclair Family's Beloved Genius